These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31083030)

  • 1. Antipsychotics Do Not Influence Neurological Soft Signs in Children and Adolescents at Ultra-High Risk for Psychosis: A Pilot Study.
    Pitzianti M; Casarelli L; Pontillo M; Vicari S; Armando M; Pasini A
    J Psychiatr Pract; 2019 May; 25(3):186-191. PubMed ID: 31083030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological soft signs: meaning and relevance along the course of psychiatric illness. An objective and rapid screening for psychosis?].
    Dimitri-Valente G; Rigucci S; Manfredi G; Girardi P; Ferracuti S
    Riv Psichiatr; 2012; 47(6):465-78. PubMed ID: 23160107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis.
    Wang Y; Braam EE; Wannan CMJ; Van Rheenen TE; Chan RCK; Nelson B; McGorry PD; Yung AR; Lin A; Brewer WJ; Koutsogiannis J; Wood SJ; Velakoulis D; Pantelis C; Cropley VL
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1475-1485. PubMed ID: 34467451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs precede the onset of schizophrenia: a study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia.
    Chan RCK; Cui HR; Chu MY; Zhang TH; Wang Y; Wang Y; Li Z; Lui SSY; Wang JJ; Cheung EFC
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):49-56. PubMed ID: 28761988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.
    Jang JH; Shin NY; Shim G; Park HY; Kim E; Jang GE; Kwon SJ; Hur JW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2011 Sep; 45(9):763-70. PubMed ID: 21827349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.
    Takahashi T; Wood SJ; Yung AR; Phillips LJ; Soulsby B; McGorry PD; Tanino R; Zhou SY; Suzuki M; Velakoulis D; Pantelis C
    Schizophr Res; 2009 Jun; 111(1-3):94-102. PubMed ID: 19349150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 22q11 microdeletion syndrome and ultra-high risk for psychosis: The role of neurological soft signs as an independent marker of vulnerability for psychosis.
    Pitzianti M; Pontillo M; Vicari S; Armando M; Pasini A
    Early Interv Psychiatry; 2019 Oct; 13(5):1191-1198. PubMed ID: 30478947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality features in ultra-high risk for psychosis: a comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R).
    Fresán A; León-Ortiz P; Robles-García R; Azcárraga M; Guizar D; Reyes-Madrigal F; Tovilla-Zárate CA; de la Fuente-Sandoval C
    J Psychiatr Res; 2015 Feb; 61():168-73. PubMed ID: 25554622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.